Search

The purpose of this study was to explore latent profiles of illness perception among cancer patients and its influencing factors. This study was a cross-sectional study adopting convenience sampling to select cancer patients from two hospitals in China. A total of 286 patients completed Brief Illness Perception Questionnaire, Post-traumatic Growth Inventory, Fear of Disease Progression Questionnaire and Psychosocial Adjustment to Illness Scale. Latent profile analysis and multiple linear regression were performed to explore the subgroups and factors influencing classification. Three subgroups were identified, which were labelled as "Moderate Illness Perception Group" (16.8%; C1), "High Illness Perception with Heightened Concerns Group" (68.5%; C2) and "High Resilience and Low Symptomatic Impact Group" (14.7%; C3). Specifically, "Normal", "Mild symptom" and "Bed time during the day <50%" of "Functional Status" were more associated with C3. "Worker", "Farmer" and "Self-employed" were more associated with C1 and C2. Patients who had more "knowledge of the disease" were more associated with C2 and C3, who had less "post-traumatic growth" were more associated with C1, and who had less "fear of disease progression" and more "psychosocial adjustment" were more associated with C3 (all P < 0.05). There was significant variability of illness perception among three subgroups of cancer patients, which emphasized the complexity of psychological condition. The insights derived from these distinct profiles enables tailored interventions and patient-centered communication strategies. However, integrating objective measures or biomarkers is needed to complement self-reported data. • Applying LPA to explore illness perception in cancer patients. • The study population includes a variety of cancer patients. • Detailed analysis of the influencing factors of each profile. • Includes discussion in a cultural and psychological perspectives. • Two sampling location. [ABSTRACT FROM AUTHOR]

Background: The accurate detection of cancer-associated venous thromboembolism (VTE) can avoid unnecessary diagnostic imaging or laboratory tests.Objective: We sought to determine clinical and cancer-related risk factors of VTE that can be used as predictors for oncology patients presenting to the emergency department (ED) with suspected VTE.Methods: We retrospectively analyzed all consecutive patients who presented with suspicion of VTE to The University of Texas MD Anderson Cancer Center ED between January 1, 2009, and January 1, 2013. Logistic regression models were used to identify risk factors that were associated with VTE. The ability of these factors to predict VTE was externally validated using a second cohort of patients who presented to King Hussein Cancer Center ED between January 1, 2009, and January 1, 2016.Results: Cancer-related covariates associated with the occurrence of VTE were high-risk cancer type (odds ratio [OR] 3.64 [95% confidence interval {CI} 2.37-5.60], p < 0.001), presentation within 6 months of the cancer diagnosis (OR 1.92 [95% CI 1.62-2.28], p < 0.001), active cancer (OR 1.35 [95% CI 1.10-1.65], p = 0.003), advanced stage (OR 1.40 [95% CI 1.01-1.94], p = 0.044), and the presence of brain metastasis (OR 1.73 [95% CI 1.32-2.27], p < 0.001). When combined, these factors along with other clinical factors showed high prediction performance for VTE in the external validation cohort.Conclusions: Cancer risk group, presentation within 6 months of cancer diagnosis, active and advanced cancer, and the presence of brain metastases along with other related clinical factors can be used to predict VTE in patients with cancer presenting to the ED. [ABSTRACT FROM AUTHOR]

The loss of open-circuit voltage is a major obstacle for approaching the theoretical value of the power conversion efficiency in hybrid perovskite solar cells. In this study, a feasible and effective strategy for modifying the interface between the perovskite and the mesoporous TiO 2 layer is proposed and implemented for the first time using 2-methylimidazole as a coating layer. As a result, the open-circuit voltage in the perovskite solar cells is significantly improved by 80 mV. The electronic impedance spectroscopy and photoluminescence spectroscopy results demonstrate that the modification of 2-methylimidazole as an interfacial insulating layer suppresses the electron transfer back from the anode electrode to the perovskite active layer, thereby inhibiting the recombination of the carriers at the interfaces, which results in an enhancement of the open-circuit voltage in the device. The cell modified with 2-methylimidazole shows increases in the open-circuit voltage from 1.05 to 1.13 V and in the power conversion efficiency from 17.48% to 19.45%. The optimal device with an area of 1 cm2 also exhibits an impressive efficiency of 16.38%. Image 1 • 2-methylimidazole was used for modifying the interface of the PSCs. • The best efficiency of 19.45% was achieved in the optimal PSCs. • 2-methylimidazole inhibited the interfacial carrier's recombination in PSCs. [ABSTRACT FROM AUTHOR]